Measurement of donor chimerism following nonmyeloablative allogeneic hematopoietic stem cell transplantation.

(A) Patient 1: assessment of granulocyte and CD3⁺ cell chimerism after transplantation. (B) Patient 2: assessment of granulocyte and CD3⁺ cell chimerism after transplantation.